Declining numbers of hepatitis C virus-associated liver transplantations in Germany : = Rückgang von Hepatitis-C-Virus-assoziierten Lebertransplantationen in Deutschland / Heiner Wedemeyer, Kerstin Herzer, Yvonne Serfert, Richard Taubert, Christian Trautwein, Dennis Eurich, Christian P. Strassburg, Melanie Lang, Karl Heinz Weiss, Thomas Berg, Peter R. Galle, Hauke Heinzow, Stefan Zeuzem, Katharina Willuweit, Theresa Kirchner, Cennet Sahin, Julius Plewe, Ulrich Spengler, Martin-Walter Welker, Martina Sterneck, Arianeb Mehrabi, Adam Herber, Tim Zimmermann, and Hartmut Schmidt
In Germany, the anti-HCV prevalence in the general population is between 0.2 and 1.9% (1). Infection with the hepatitis C virus (HCV) can result in chronic liver disease, the complications of which are liver cirrhosis and hepatocellular carcinoma (HCC). Thus, for many years, HCV infection was one of the most common indications for liver transplantation secondary to decompensated cirrhosis or HCC. Over the past ten years, between 800 and 1200 liver transplantations have been performed in Germany each year. With the introduction of highly effective and safe direct antiviral agents (DAAs) against HCV in 2014, the question arose as to what extent the need for HCV-related liver transplantations has decreased since then. In an initial analysis involving eleven German transplant centers, we already found evidence in 2016 that the proportion of patients with HCV-related liver transplantation was in decline after the introduction of DAA in Germany (2). In this paper we present a follow-up of this study..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 Nov 19 2021 |
---|---|
Erschienen: |
2021 Nov 19 |
Enthalten in: |
Zur Gesamtaufnahme - volume:118 |
---|---|
Enthalten in: |
Deutsches Ärzteblatt international - 118(2021), 46 vom: Nov., Seite 797-798 |
Sprache: |
Englisch |
---|
Weiterer Titel: |
Rückgang von Hepatitis-C-Virus-assoziierten Lebertransplantationen in Deutschland |
---|
Beteiligte Personen: |
Wedemeyer, Heiner, 1967- [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Gesehen am 12.05.2022 |
---|
Umfang: |
2 |
---|
doi: |
10.3238/arztebl.m2021.0318 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1801648689 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | 1801648689 | ||
003 | DE-627 | ||
005 | 20230426073509.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220512s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3238/arztebl.m2021.0318 |2 doi | |
035 | |a (DE-627)1801648689 | ||
035 | |a (DE-599)KXP1801648689 | ||
035 | |a (OCoLC)1341459865 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Wedemeyer, Heiner |d 1967- |e verfasserin |0 (DE-588)124865798 |0 (DE-627)483646016 |0 (DE-576)294541853 |4 aut | |
245 | 1 | 0 | |a Declining numbers of hepatitis C virus-associated liver transplantations in Germany |b = Rückgang von Hepatitis-C-Virus-assoziierten Lebertransplantationen in Deutschland |c Heiner Wedemeyer, Kerstin Herzer, Yvonne Serfert, Richard Taubert, Christian Trautwein, Dennis Eurich, Christian P. Strassburg, Melanie Lang, Karl Heinz Weiss, Thomas Berg, Peter R. Galle, Hauke Heinzow, Stefan Zeuzem, Katharina Willuweit, Theresa Kirchner, Cennet Sahin, Julius Plewe, Ulrich Spengler, Martin-Walter Welker, Martina Sterneck, Arianeb Mehrabi, Adam Herber, Tim Zimmermann, and Hartmut Schmidt |
246 | 3 | 1 | |a Rückgang von Hepatitis-C-Virus-assoziierten Lebertransplantationen in Deutschland |
264 | 1 | |c 2021 Nov 19 | |
300 | |a 2 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Gesehen am 12.05.2022 | ||
520 | |a In Germany, the anti-HCV prevalence in the general population is between 0.2 and 1.9% (1). Infection with the hepatitis C virus (HCV) can result in chronic liver disease, the complications of which are liver cirrhosis and hepatocellular carcinoma (HCC). Thus, for many years, HCV infection was one of the most common indications for liver transplantation secondary to decompensated cirrhosis or HCC. Over the past ten years, between 800 and 1200 liver transplantations have been performed in Germany each year. With the introduction of highly effective and safe direct antiviral agents (DAAs) against HCV in 2014, the question arose as to what extent the need for HCV-related liver transplantations has decreased since then. In an initial analysis involving eleven German transplant centers, we already found evidence in 2016 that the proportion of patients with HCV-related liver transplantation was in decline after the introduction of DAA in Germany (2). In this paper we present a follow-up of this study. | ||
700 | 1 | |a Herzer, Kerstin |e verfasserin |4 aut | |
700 | 1 | |a Serfert, Yvonne |e verfasserin |4 aut | |
700 | 1 | |a Taubert, Richard |e verfasserin |4 aut | |
700 | 1 | |a Trautwein, Christian |e verfasserin |4 aut | |
700 | 1 | |a Eurich, Dennis |e verfasserin |4 aut | |
700 | 1 | |a Strassburg, Christian P. |e verfasserin |4 aut | |
700 | 1 | |a Lang, Melanie |e verfasserin |4 aut | |
700 | 1 | |a Weiss, Karl Heinz |d 1976- |e verfasserin |0 (DE-588)130069531 |0 (DE-627)489615465 |0 (DE-576)297980203 |4 aut | |
700 | 1 | |a Berg, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Galle, Peter R. |e verfasserin |4 aut | |
700 | 1 | |a Heinzow, Hauke |e verfasserin |4 aut | |
700 | 1 | |a Zeuzem, Stefan |e verfasserin |4 aut | |
700 | 1 | |a Willuweit, Katharina |e verfasserin |4 aut | |
700 | 1 | |a Kirchner, Theresa |e verfasserin |4 aut | |
700 | 1 | |a Sahin, Cennet |e verfasserin |4 aut | |
700 | 1 | |a Plewe, Julius |e verfasserin |4 aut | |
700 | 1 | |a Spengler, Ulrich |e verfasserin |4 aut | |
700 | 1 | |a Welker, Martin-Walter |e verfasserin |4 aut | |
700 | 1 | |a Sterneck, Martina |e verfasserin |4 aut | |
700 | 1 | |a Mehrabi, Arianeb |d 1967- |e verfasserin |0 (DE-588)137664583 |0 (DE-627)594829763 |0 (DE-576)304831263 |4 aut | |
700 | 1 | |a Herber, Adam |e verfasserin |4 aut | |
700 | 1 | |a Zimmermann, Tim |e verfasserin |4 aut | |
700 | 1 | |a Schmidt, Hartmut |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Deutsches Ärzteblatt international |d Köln : Dt. Ärzte-Verl., 2006 |g 118(2021), 46 vom: Nov., Seite 797-798 |h Online-Ressource |w (DE-627)557878810 |w (DE-600)2406159-1 |w (DE-576)281368007 |x 1866-0452 |7 nnns |
773 | 1 | 8 | |g volume:118 |g year:2021 |g number:46 |g month:11 |g pages:797-798 |g extent:2 |
775 | 0 | 8 | |i Parallele Sprachausgabe |n deutsch |a Wedemeyer, Heiner, 1967 - |t Rückgang von Hepatitis-C-Virus-assoziierten Lebertransplantationen in Deutschland |d 2021 |w (DE-627)180165221X |
856 | 4 | 0 | |u https://doi.org/10.3238/arztebl.m2021.0318 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864669/ |x Verlag |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ILN_2013 | ||
912 | |a ISIL_DE-16-250 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_150 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_702 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2018 | ||
912 | |a GBV_ILN_2020 | ||
912 | |a GBV_ILN_2034 | ||
912 | |a GBV_ILN_2106 | ||
912 | |a GBV_ILN_2147 | ||
912 | |a GBV_ILN_2148 | ||
912 | |a GBV_ILN_2190 | ||
912 | |a GBV_ILN_2232 | ||
912 | |a GBV_ILN_2446 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4335 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
936 | u | w | |d 118 |j 2021 |e 46 |c 11 |h 797-798 |g 2 |
951 | |a AR | ||
952 | |d 118 |j 2021 |e 46 |c 11 |h 797-798 |g 2 | ||
980 | |2 2013 |1 01 |x DE-16-250 |b 4133021533 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 12-05-22 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd2021 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1410508463 |a wissenschaftlicher Artikel (Zeitschrift) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_13 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_2 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)1469113848 |a Weiss, Karl Heinz | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_9 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s p |0 (DE-627)1484043162 |a Mehrabi, Arianeb | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s k |0 (DE-627)1416740848 |a Chirurgische Universitätsklinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |a pos_21 |